|Citrobacter rodentium of mice and man|
R Mundy, TT MacDonald, G Dougan, G Frankel, S Wiles
Cellular microbiology 7 (12), 1697-1706, 2005
|Optimisation of bioluminescent reporters for use with mycobacteria|
N Andreu, A Zelmer, T Fletcher, PT Elkington, TH Ward, J Ripoll, T Parish, ...
PloS one 5 (5), e10777, 2010
|Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium|
S Wiles, S Clare, J Harker, A Huett, D Young, G Dougan, G Frankel
Cellular microbiology 6 (10), 963-972, 2004
|Tetracycline-inducible gene regulation in mycobacteria|
MCJ Blokpoel, HN Murphy, R O'Toole, S Wiles, ESC Runn, GR Stewart, ...
Nucleic acids research 33 (2), e22-e22, 2005
|Essential Role of the Type III Secretion System Effector NleB in Colonization of Mice by Citrobacter rodentium|
M Kelly, E Hart, R Mundy, O Marches, S Wiles, L Badea, S Luck, ...
Infection and immunity 74 (4), 2328-2337, 2006
|Noninvasive biophotonic imaging for studies of infectious disease|
N Andreu, A Zelmer, S Wiles
FEMS microbiology reviews 35 (2), 360-394, 2011
|Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters|
P Carroll, LJ Schreuder, J Muwanguzi-Karugaba, S Wiles, BD Robertson, ...
PloS one 5 (3), e9823, 2010
|In Vivo Bioluminescence Imaging of the Murine Pathogen Citrobacter rodentium|
S Wiles, KM Pickard, K Peng, TT MacDonald, G Frankel
Infection and immunity 74 (9), 5391-5396, 2006
|Galleria mellonella larvae as an infection model for group A streptococcus|
JMS Loh, N Adenwalla, S Wiles, T Proft
Virulence 4 (5), 419-428, 2013
|Whole cell immobilised biosensors for toxicity assessment of a wastewater treatment plant treating phenolics-containing waste|
JC Philp, S Balmand, E Hajto, MJ Bailey, S Wiles, AS Whiteley, AK Lilley, ...
Analytica Chimica Acta 487 (1), 61-74, 2003
|EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics|
S Dahan, S Wiles, RM La Ragione, A Best, MJ Woodward, MP Stevens, ...
Infection and Immunity 73 (2), 679-686, 2005
|Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence|
N Andreu, T Fletcher, N Krishnan, S Wiles, BD Robertson
Journal of Antimicrobial Chemotherapy 67 (2), 404-414, 2012
|Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs|
K Montrose, Y Yang, X Sun, S Wiles, GW Krissansen
Scientific reports 3 (1), 1-7, 2013
|Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens|
O Marchés, S Wiles, F Dziva, RM La Ragione, S Schüller, A Best, ...
Infection and immunity 73 (12), 8411-8417, 2005
|Emergence of a ‘hyperinfectious’ bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract|
S Wiles, G Dougan, G Frankel
Cellular microbiology 7 (8), 1163-1172, 2005
|A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging|
A Zelmer, P Carroll, N Andreu, K Hagens, J Mahlo, N Redinger, ...
Journal of antimicrobial chemotherapy 67 (8), 1948-1960, 2012
|Alternative luciferase for monitoring bacterial cells under adverse conditions|
S Wiles, K Ferguson, M Stefanidou, DB Young, BD Robertson
Applied and environmental microbiology 71 (7), 3427-3432, 2005
|Ecological and physiological analyses of Pseudomonad species within a phenol remediation system|
AS Whiteley, S Wiles, AK Lilley, J Philp, MJ Bailey
Journal of microbiological methods 44 (1), 79-88, 2001
|Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase|
N Andreu, A Zelmer, SL Sampson, M Ikeh, GJ Bancroft, UE Schaible, ...
Journal of Antimicrobial Chemotherapy 68 (9), 2118-2127, 2013
|Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi|
CE Turner, P Kurupati, S Wiles, RJ Edwards, S Sriskandan
Vaccine 27 (36), 4923-4929, 2009